India-focused venture firm Saama Capital has invested in a diagnostics company in its latest transaction, a person privy to the development told VCCircle. The firm has made an investment in Pune-based GenePath Diagnostics, which builds in vitro molecular diagnostic and genetic and genomic testing kits, among others. The financial details of ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.